Preparation of biologically active and site specifically radioiodinated recombinant human insulin-like growth factor-I. 1992

Y Kohama, and M Okabe, and K Tsujikawa, and H Oka, and T Teramoto, and Y Kayamori, and M Itoh, and T Mimura
Faculty of Pharmaceutical Sciences, Osaka University, Japan.

Recombinant human insulin-like growth factor-I (rhIGF-I) was iodinated using a lactoperoxidase-catalyzed labeling method. The labeled products were separated into more than five fractions by ion-paired reverse-phase high performance liquid chromatography (HPLC). A fraction (peak 1), which showed the highest yield and radioactivity, was found to be biologically active in the BALB/c 3T3 cell proliferating system. The site of the iodination was investigated by S-pyridylethylation followed by trypsinization and separation with HPLC using reverse phase columns. From the amino acid analysis of the peaks which were radioactive, the iodination site of peak 1 was revealed to be Tyr-24 and Tyr-60. This is the first report of the biological activity of radioactive peptide hormone with a defined labeled site.

UI MeSH Term Description Entries
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D007553 Isotope Labeling Techniques for labeling a substance with a stable or radioactive isotope. It is not used for articles involving labeled substances unless the methods of labeling are substantively discussed. Tracers that may be labeled include chemical substances, cells, or microorganisms. Isotope Labeling, Stable,Isotope-Coded Affinity Tagging,Isotopically-Coded Affinity Tagging,Affinity Tagging, Isotope-Coded,Affinity Tagging, Isotopically-Coded,Isotope Coded Affinity Tagging,Labeling, Isotope,Labeling, Stable Isotope,Stable Isotope Labeling,Tagging, Isotope-Coded Affinity,Tagging, Isotopically-Coded Affinity
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Y Kohama, and M Okabe, and K Tsujikawa, and H Oka, and T Teramoto, and Y Kayamori, and M Itoh, and T Mimura
January 2009, Advances in therapy,
Y Kohama, and M Okabe, and K Tsujikawa, and H Oka, and T Teramoto, and Y Kayamori, and M Itoh, and T Mimura
December 1985, The Journal of biological chemistry,
Y Kohama, and M Okabe, and K Tsujikawa, and H Oka, and T Teramoto, and Y Kayamori, and M Itoh, and T Mimura
November 1977, Endocrinology,
Y Kohama, and M Okabe, and K Tsujikawa, and H Oka, and T Teramoto, and Y Kayamori, and M Itoh, and T Mimura
January 1998, Methods in molecular biology (Clifton, N.J.),
Y Kohama, and M Okabe, and K Tsujikawa, and H Oka, and T Teramoto, and Y Kayamori, and M Itoh, and T Mimura
January 1985, Gene,
Y Kohama, and M Okabe, and K Tsujikawa, and H Oka, and T Teramoto, and Y Kayamori, and M Itoh, and T Mimura
July 1992, Clinical endocrinology,
Y Kohama, and M Okabe, and K Tsujikawa, and H Oka, and T Teramoto, and Y Kayamori, and M Itoh, and T Mimura
August 1998, Protein expression and purification,
Y Kohama, and M Okabe, and K Tsujikawa, and H Oka, and T Teramoto, and Y Kayamori, and M Itoh, and T Mimura
July 1994, The Journal of clinical endocrinology and metabolism,
Y Kohama, and M Okabe, and K Tsujikawa, and H Oka, and T Teramoto, and Y Kayamori, and M Itoh, and T Mimura
January 1989, Neurobiology of aging,
Y Kohama, and M Okabe, and K Tsujikawa, and H Oka, and T Teramoto, and Y Kayamori, and M Itoh, and T Mimura
April 1988, Endocrinology,
Copied contents to your clipboard!